Esomeprazole Market Key Findings by 2031
Esomeprazole is a drug that is used as a medication that reduces stomach acid. It is used to treat gastroesophageal reflux disease, Zollinger-Ellison syndrome, and peptic ulcers. It is similar to the other proton pump inhibitors. It is also used to treat frequent heartburn in adults.
MARKET SCOPE
The "Global Esomeprazole Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Esomeprazole market with detailed market segmentation by product and application. The report provides key statistics on the market status of the leading Esomeprazole market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on product the market is segmented as, capsule, tablet, and others.
- Based on the application the market is segmented as, gastroesophageal reflux disease, duodenal ulcers, efficacy, others.
MARKET DYNAMICS
Drivers:
- Rising prevalence of heartburn, peptic ulcers disease, gastroesophageal disease, and Zollinger-Ellison syndrome.
- Increasing preference for junk food and modern lifestyle results in ulcers and gastroesophageal disease.
- Extensive R&D efforts by pharmaceutical companies to develop novel therapies for gastroesophageal disease are expected to fuel market growth.
Restraints:
- Whereas, the high cost of treatment for Zollinger-Ellison syndrome and gastroesophageal disease is expected to restrain the market growth during the forecast period.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 concerning five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South and Central America. The Esomeprazole market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South and Central America after evaluating political, economic, social, and technological factors affecting the Esomeprazole market in these regions.
IMPACT OF COVID-19 ON ESOMEPRAZOLE MARKET
COVID-19 first began in Wuhan (China) in December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in the global market. Few companies have already announced possible delays in product deliveries and slumps in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 concerning five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South and Central America. The Esomeprazole market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South and Central America after evaluating political, economic, social, and technological factors affecting the Esomeprazole market in these regions.
IMPACT OF COVID-19 ON ESOMEPRAZOLE MARKET
COVID-19 first began in Wuhan (China) in December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in the global market. Few companies have already announced possible delays in product deliveries and slumps in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the Esomeprazole market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnerships & collaborations. These activities have paved the way for the expansion of business and the customer base of market players. The market payers from the Esomeprazole market are anticipated to have lucrative growth opportunities in the future with the rising demand for Esomeprazole in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Esomeprazole market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- TEVA, BLASKOV
- ASTRA ZENECA AB
- GARMISH PHARMACEUTICAL
- MEPHA
- CQ LUMMY
- STADA
- ACTAVIS
- MYLAN
- SANDOZ
- SANOFI
- SAVAL PHARMACEUTICAL
- KERN PHARM
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Esomeprazole Market - By Product
1.3.2 Esomeprazole Market - By Application
1.3.3 Esomeprazole Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ESOMEPRAZOLE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ESOMEPRAZOLE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ESOMEPRAZOLE MARKET - GLOBAL MARKET ANALYSIS
6.1. ESOMEPRAZOLE - GLOBAL MARKET OVERVIEW
6.2. ESOMEPRAZOLE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. ESOMEPRAZOLE MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. CAPSULE
7.3.1. Overview
7.3.2. Capsule Market Forecast and Analysis
7.4. TABLET
7.4.1. Overview
7.4.2. Tablet Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. ESOMEPRAZOLE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. GASTROESOPHAGEAL REFLUX DISEASE
8.3.1. Overview
8.3.2. Gastroesophageal reflux disease Market Forecast and Analysis
8.4. DUODENAL ULCERS
8.4.1. Overview
8.4.2. Duodenal ulcers Market Forecast and Analysis
8.5. EFFICACY
8.5.1. Overview
8.5.2. Efficacy Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. ESOMEPRAZOLE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Esomeprazole Market Overview
9.1.2 North America Esomeprazole Market Forecasts and Analysis
9.1.3 North America Esomeprazole Market Forecasts and Analysis - By Product
9.1.4 North America Esomeprazole Market Forecasts and Analysis - By Application
9.1.5 North America Esomeprazole Market Forecasts and Analysis - By Countries
9.1.5.1 United States Esomeprazole Market
9.1.5.1.1 United States Esomeprazole Market by Product
9.1.5.1.2 United States Esomeprazole Market by Application
9.1.5.2 Canada Esomeprazole Market
9.1.5.2.1 Canada Esomeprazole Market by Product
9.1.5.2.2 Canada Esomeprazole Market by Application
9.1.5.3 Mexico Esomeprazole Market
9.1.5.3.1 Mexico Esomeprazole Market by Product
9.1.5.3.2 Mexico Esomeprazole Market by Application
9.2. EUROPE
9.2.1 Europe Esomeprazole Market Overview
9.2.2 Europe Esomeprazole Market Forecasts and Analysis
9.2.3 Europe Esomeprazole Market Forecasts and Analysis - By Product
9.2.4 Europe Esomeprazole Market Forecasts and Analysis - By Application
9.2.5 Europe Esomeprazole Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Esomeprazole Market
9.2.5.1.1 Germany Esomeprazole Market by Product
9.2.5.1.2 Germany Esomeprazole Market by Application
9.2.5.2 France Esomeprazole Market
9.2.5.2.1 France Esomeprazole Market by Product
9.2.5.2.2 France Esomeprazole Market by Application
9.2.5.3 Italy Esomeprazole Market
9.2.5.3.1 Italy Esomeprazole Market by Product
9.2.5.3.2 Italy Esomeprazole Market by Application
9.2.5.4 Spain Esomeprazole Market
9.2.5.4.1 Spain Esomeprazole Market by Product
9.2.5.4.2 Spain Esomeprazole Market by Application
9.2.5.5 United Kingdom Esomeprazole Market
9.2.5.5.1 United Kingdom Esomeprazole Market by Product
9.2.5.5.2 United Kingdom Esomeprazole Market by Application
9.2.5.6 Rest of Europe Esomeprazole Market
9.2.5.6.1 Rest of Europe Esomeprazole Market by Product
9.2.5.6.2 Rest of Europe Esomeprazole Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Esomeprazole Market Overview
9.3.2 Asia-Pacific Esomeprazole Market Forecasts and Analysis
9.3.3 Asia-Pacific Esomeprazole Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Esomeprazole Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Esomeprazole Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Esomeprazole Market
9.3.5.1.1 Australia Esomeprazole Market by Product
9.3.5.1.2 Australia Esomeprazole Market by Application
9.3.5.2 China Esomeprazole Market
9.3.5.2.1 China Esomeprazole Market by Product
9.3.5.2.2 China Esomeprazole Market by Application
9.3.5.3 India Esomeprazole Market
9.3.5.3.1 India Esomeprazole Market by Product
9.3.5.3.2 India Esomeprazole Market by Application
9.3.5.4 Japan Esomeprazole Market
9.3.5.4.1 Japan Esomeprazole Market by Product
9.3.5.4.2 Japan Esomeprazole Market by Application
9.3.5.5 South Korea Esomeprazole Market
9.3.5.5.1 South Korea Esomeprazole Market by Product
9.3.5.5.2 South Korea Esomeprazole Market by Application
9.3.5.6 Rest of Asia-Pacific Esomeprazole Market
9.3.5.6.1 Rest of Asia-Pacific Esomeprazole Market by Product
9.3.5.6.2 Rest of Asia-Pacific Esomeprazole Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Esomeprazole Market Overview
9.4.2 Middle East and Africa Esomeprazole Market Forecasts and Analysis
9.4.3 Middle East and Africa Esomeprazole Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Esomeprazole Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Esomeprazole Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Esomeprazole Market
9.4.5.1.1 South Africa Esomeprazole Market by Product
9.4.5.1.2 South Africa Esomeprazole Market by Application
9.4.5.2 Saudi Arabia Esomeprazole Market
9.4.5.2.1 Saudi Arabia Esomeprazole Market by Product
9.4.5.2.2 Saudi Arabia Esomeprazole Market by Application
9.4.5.3 U.A.E Esomeprazole Market
9.4.5.3.1 U.A.E Esomeprazole Market by Product
9.4.5.3.2 U.A.E Esomeprazole Market by Application
9.4.5.4 Rest of Middle East and Africa Esomeprazole Market
9.4.5.4.1 Rest of Middle East and Africa Esomeprazole Market by Product
9.4.5.4.2 Rest of Middle East and Africa Esomeprazole Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Esomeprazole Market Overview
9.5.2 South and Central America Esomeprazole Market Forecasts and Analysis
9.5.3 South and Central America Esomeprazole Market Forecasts and Analysis - By Product
9.5.4 South and Central America Esomeprazole Market Forecasts and Analysis - By Application
9.5.5 South and Central America Esomeprazole Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Esomeprazole Market
9.5.5.1.1 Brazil Esomeprazole Market by Product
9.5.5.1.2 Brazil Esomeprazole Market by Application
9.5.5.2 Argentina Esomeprazole Market
9.5.5.2.1 Argentina Esomeprazole Market by Product
9.5.5.2.2 Argentina Esomeprazole Market by Application
9.5.5.3 Rest of South and Central America Esomeprazole Market
9.5.5.3.1 Rest of South and Central America Esomeprazole Market by Product
9.5.5.3.2 Rest of South and Central America Esomeprazole Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ESOMEPRAZOLE MARKET, KEY COMPANY PROFILES
11.1. TEVA, BLASKOV
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ASTRA ZENECA AB
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GARMISH PHARMACEUTICAL
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. MEPHA
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CQ LUMMY
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. STADA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ACTAVIS
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MYLAN
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SANDOZ
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SANOFI
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
11.11. SAVAL PHARMACEUTICAL
11.11.1. Key Facts
11.11.2. Business Description
11.11.3. Products and Services
11.11.4. Financial Overview
11.11.5. SWOT Analysis
11.11.6. Key Developments
11.12. KERN PHARM
11.12.1. Key Facts
11.12.2. Business Description
11.12.3. Products and Services
11.12.4. Financial Overview
11.12.5. SWOT Analysis
11.12.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1.Teva, Blaskov
2.Astra Zeneca AB
3.Garmish Pharmaceutical
4.Mepha
5.CQ Lummy
6.Stada
7.Actavis
8.Mylan
9.Sandoz
10.Sanofi
11.Saval Pharmaceutical
12.Kern Pharm
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For